3-hydroxybutyric acid은 임신 중 안전한가요?
No evidence of reproductive or teratogenic effects in available regulatory summaries. PubChem GHS entries list skin/eye irritation (H315, H319, H335) but these are aggregated notifications and not harmonised reproductive classifications. No harmonised CLP (ECHA Annex VI) reproductive flags or SCCS/CIR safety assessment found in the provided sources, so hazard and mechanism scores remain 0. Systemic exposure from topical use is expected to be low but measurable (small, water‑soluble molecule), so exposure = 1 (low). Sources: PubChem GHS (aggregate notifications); absence of harmonised classification in ECHA Annex VI / no SCCS/CIR found in provided databases.
Related ingredients
Frequently asked questions
- 3-hydroxybutyric acid은 임신 중 안전한가요?
- No evidence of reproductive or teratogenic effects in available regulatory summaries. PubChem GHS entries list skin/eye irritation (H315, H319, H335) but these are aggregated notifications and not harmonised reproductive classifications. No harmonised CLP (ECHA Annex VI) reproductive flags or SCCS/CIR safety assessment found in the provided sources, so hazard and mechanism scores remain 0. Systemic exposure from topical use is expected to be low but measurable (small, water‑soluble molecule), so exposure = 1 (low). Sources: PubChem GHS (aggregate notifications); absence of harmonised classification in ECHA Annex VI / no SCCS/CIR found in provided databases.
- 3-hydroxybutyric acid은 모유 수유 중 안전한가요?
- No data indicating reproductive or lactation-specific toxicity. As an endogenous small molecule (beta/3‑hydroxybutyric acid is a normal ketone body), no signals for lactation hazards were identified in the provided regulatory sources. Topical cosmetic use could produce low systemic levels — therefore exposure scored as 1 (low). Sources: PubChem GHS; no SCCS/CIR or harmonised ECHA reproductive classification identified.
- 3-hydroxybutyric acid은 아기 피부에 안전한가요?
- No infant-specific developmental toxicity evidence located in the provided sources. Hazard and mechanism remain 0. Because infant skin has a higher surface‑area‑to‑weight ratio and immature barrier, exposure score is increased by +1 relative to adult topical use (adult e=1 → infant e=2), reflecting moderate potential for percutaneous absorption in 0–3 yr olds. Sources: PubChem GHS (aggregate notifications); ECHA/CosIng/CIR searches yielded no harmonised reproductive or infant‑specific safety assessments in the provided dataset.
- VeriMom은 3-hydroxybutyric acid을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 3-hydroxybutyric acid을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 3-hydroxybutyric acid 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.